GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

VIVA Biotech Holdings 1873.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

1.32

-1.49%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥2.02bn

FY2016FY2025

Net income

CN¥256.3m

FY2016FY2025

Free cash flow

CN¥102.6m

FY2016FY2025

Shareholders' equity

CN¥4.66bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥2.02bnCN¥1.99bnCN¥2.16bnCN¥2.38bnCN¥2.45bnCN¥697.0mCN¥323.1mCN¥210.0mCN¥148.2mCN¥96.5m
Research and developmentCN¥117.1mCN¥88.0mCN¥128.0mCN¥135.8mCN¥107.7mCN¥66.0mCN¥45.0mCN¥25.3mCN¥17.3mCN¥16.8m
Operating incomeCN¥225.3mCN¥229.7mCN¥192.7mCN¥269.3mCN¥276.2mCN¥115.6mCN¥54.3mCN¥50.6mCN¥52.8mCN¥28.4m
Net incomeCN¥256.3mCN¥167.3m−CN¥116.1m−CN¥528.5mCN¥335.3m−CN¥386.9mCN¥265.9mCN¥90.5mCN¥76.3mCN¥24.5m
Diluted earnings per share0.120.05-0.05-0.280.17-0.200.170.080.050.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥8.40bnCN¥8.22bnCN¥8.69bnCN¥9.24bnCN¥9.38bnCN¥8.15bnCN¥1.90bnCN¥529.3mCN¥202.4mCN¥101.8m
Cash and short-term investmentsCN¥1.32bnCN¥1.10bnCN¥1.21bnCN¥791.3mCN¥934.0mCN¥2.36bnCN¥933.7mCN¥155.6mCN¥33.3mCN¥13.4m
Total liabilitiesCN¥3.72bnCN¥3.77bnCN¥4.39bnCN¥5.03bnCN¥4.82bnCN¥4.40bnCN¥121.4mCN¥277.9mCN¥49.6mCN¥25.3m
DebtCN¥1.55bnCN¥1.28bnCN¥1.91bnCN¥2.82bnCN¥2.65bnCN¥2.97bnCN¥49.4mCN¥2.4mCN¥14.9mCN¥3.5m
Shareholders' equityCN¥4.66bnCN¥4.43bnCN¥4.30bnCN¥4.20bnCN¥4.56bnCN¥3.76bnCN¥1.78bnCN¥251.4mCN¥152.8mCN¥76.5m
Shares outstanding2,170m3,595m2,140m1,915m2,008m1,912m1,562m1,203m1,500m1,500m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥240.3mCN¥374.0mCN¥447.1mCN¥450.2mCN¥90.8mCN¥43.2mCN¥46.0mCN¥12.1mCN¥27.9mCN¥21.1m
Capital spending−CN¥137.6m−CN¥191.7m−CN¥219.0m−CN¥290.7m−CN¥659.0m−CN¥592.6m−CN¥56.2m−CN¥46.9m−CN¥18.9m−CN¥7.3m
Free cash flowCN¥102.6mCN¥182.3mCN¥228.0mCN¥159.4m−CN¥568.3m−CN¥549.4m−CN¥10.2m−CN¥34.8mCN¥9.0mCN¥13.8m
Dividends paid————−CN¥19.0m−CN¥51.8m−CN¥135.8m−CN¥15.1m−CN¥15.1m—

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥1.16bnCN¥1.05bnCN¥970.0mCN¥1.00bnCN¥981.8mCN¥1.01bnCN¥1.33bnCN¥1.48bn
Operating incomeCN¥131.3mCN¥90.3mCN¥135.0mCN¥108.1mCN¥121.6mCN¥67.3mCN¥145.6mCN¥192.6m
Net incomeCN¥92.1mCN¥114.2mCN¥142.0mCN¥50.5mCN¥116.8m−CN¥117.1mCN¥1.2m−CN¥509.9m
Diluted earnings per share0.040.050.070.010.03-0.050.00-0.27
Cash from operationsCN¥390.0mCN¥107.0mCN¥151.0mCN¥221.0mCN¥152.0mCN¥76.0mCN¥370.0mCN¥342.0m
Capital spending−CN¥111.0m−CN¥55.0m−CN¥87.0m−CN¥62.0m−CN¥128.0m−CN¥100.0m−CN¥118.0m−CN¥131.0m
Free cash flowCN¥279.0mCN¥52.0mCN¥64.0mCN¥159.0mCN¥24.0m−CN¥24.0mCN¥252.0mCN¥211.0m
Total assetsCN¥8.04bnCN¥8.40bnCN¥8.03bnCN¥7.05bnCN¥7.18bnCN¥7.45bnCN¥9.50bnCN¥9.24bn
Cash and short-term investmentsCN¥1.23bnCN¥1.32bnCN¥1.05bnCN¥941.6mCN¥1.04bnCN¥1.04bnCN¥1.25bnCN¥791.3m
DebtCN¥697.8mCN¥1.55bnCN¥1.35bnCN¥1.28bnCN¥1.54bnCN¥1.90bnCN¥3.39bnCN¥3.29bn
Shareholders' equityCN¥4.62bnCN¥4.66bnCN¥4.54bnCN¥3.80bnCN¥3.79bnCN¥3.69bnCN¥4.24bnCN¥4.20bn

Financial ratios

Data as of 18 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin11.2%11.6%8.9%11.2%11.3%16.1%
Net margin12.7%8.4%-5.4%-22.2%13.7%-55.5%
Return on equity5.5%4.4%-3.1%-14.7%7.3%-10.3%
Return on assets3.1%2.4%-1.6%-6.7%3.6%-4.7%
Free cash flow yield6.9%7.6%13.1%14.7%2.8%1.6%
Revenue growth-12.9%-7.8%-9.4%13.1%201.9%115.7%
Earnings growth31.4%-244.1%-78.0%-283.8%-174.3%-245.5%
Current ratio1.50x1.67x1.32x0.73x2.14x4.56x
Debt to equity0.33x0.33x0.51x0.78x0.67x0.79x
Equity ratio55.5%53.9%49.5%45.5%48.6%46.1%
Interest coverage5.29x4.26x1.09x1.44x1.29x1.81x
R&D as a share of sales5.8%4.4%5.9%5.7%4.4%9.5%
Buybacks as a share of market value39.6%-68.0%-11.7%4.6%-5.0%-22.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.5%27.0%—
Operating income-5.8%14.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings13.216.2-16.8-5.524.4-39.223.2
Price to sales1.71.41.11.44.025.818.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 16 Jun 2021.

FY2021FY2020FY2019
Paid in the year0.010.0320.005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.